#United States #Goldman Sachs #Boston #Haemonetics #Chris Simon

Haemonetics Corporation's Upcoming Presentation at Goldman Sachs

Haemonetics Corporation, known for its ground-breaking innovations in healthcare technology, has announced an important engagement at the upcoming Goldman Sachs 47th Annual Global Healthcare Conference. The company's President and CEO, Chris Simon, will participate in a fireside chat aimed at addressing key issues in the healthcare sector while connecting with investors and stakeholders.

Event Details

The fireside chat is scheduled for June 8, 2026, at 4:00 PM ET. This engaging session will provide insights into the company's strategies, future plans, and responses to current trends in the medical technology landscape. Investors and interested members of the public can tune in to a live webcast of the discussion through the Haemonetics Investor Relations website or directly via a provided link.

After the live event, a replay of the chat will be accessible for 90 days, allowing a wider audience to gain insights into Haemonetics' operations and vision.

Company Overview

Haemonetics is a global leader in the field of medical technology, focusing on improving healthcare quality and efficiency. The firm develops a range of innovative solutions tailored to address critical medical needs. Their product offerings include:

• - Hospital Technologies: Designed to enhance patient care standards.
• - Plasma Collection Technologies: These solutions optimize operational efficiency in plasma centers, key for blood component supply chains.
• - Blood Center Products: These allow blood centers to efficiently collect and manage in-demand blood components.

Significance of the Event

Participating in prestigious conferences such as Goldman Sachs' is not just an opportunity for Haemonetics to demonstrate its advancements but also serves as a platform for dialogue about the evolving challenges and opportunities in the healthcare sector. Chris Simon's leadership is pivotal as the company navigates the intricate dynamics of healthcare demands and technological advancements.

This presentation aims to provide investors with clearer direction regarding Haemonetics' business practices and market positioning. Given the rapid transformations in healthcare technology, such forums allow stakeholders to remain informed about the company's direction and the broader industry context.

Accessibility and Engagement

For those interested in following along, the accessibility of the webcast underscores Haemonetics’ commitment to transparent communication with its stakeholders. By offering both live access and recorded replays, the company ensures that valuable information is available to all, fostering an inclusive environment for investor engagement.

In summary, the upcoming fireside chat at Goldman Sachs presents a significant opportunity for Haemonetics to showcase its initiatives and engagement strategies within the healthcare sector. With Chris Simon at the helm, stakeholders look forward to gaining a deeper understanding of the company's role in shaping the future of healthcare technology.

To learn more about Haemonetics and its innovative solutions, visit their official website www.haemonetics.com.